RIVAROXABAN Vascular Zentiva 2,5 mg cpr pellic196

7680687490047 CH-68749 B01AF01 06.03.0.

Active substances:

No images available

Details

Product number
6874901
CPT
-
Packaging group
196
Unit
Tablette(n)
Composition
rivaroxabanum 2.5 mg, lactosum monohydricum 28.50 mg, carmellosum natricum conexum, hypromellosum, cellulosum microcristallinum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, macrogolum 3350, E 172 (flavum), pro compresso obducto corresp. natrium 0.44 mg.

Articles (1)

Rivaroxaban Vascular Zentiva 2,5 mg, Filmtabletten
Filmtabletten
196
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/07/2026
Patient information leaflet
Français
23/07/2026
Patient information leaflet
Italien
23/07/2026
Professional SmPC
Allemand
23/07/2026
Professional SmPC
Français
23/07/2026
Professional SmPC
Italien
23/07/2026

Detailed composition

Substance Quantity Type Category
rivaroxabanum
2.5 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
28.5 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
hypromellosum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
natrium
0.44 MG Substance HBESI

Reimbursement information

Public price
CHF 118.45
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
68749
Drug name
Rivaroxaban Vascular Zentiva, Filmtabletten
Galenic form
FILM
ATC Code
B01AF01
Authorization status
Z
Dispensation category
B
First authorization
20/06/2024
Authorization expiration date
19/06/2029
IT number
06.03.0.
Domain
Human medicine
Field of application
In Kombination mit Acetylsalicylsäure zur Prävention schwerwiegender atherothrombotischer Ereignisse bei Patienten mit koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse

Packaging details

Description (FR)
RIVAROXABAN Vascular Zentiva 2,5 mg cpr pellic196
Description (DE)
RIVAROXABAN Vascular Zentiva 2,5 mg Filmtabl 196
Market launch
01/04/2026
Narcotic (BTM)
No

Original drug

Xarelto, Filmtabletten
CHF 15.30
View original

Other packaging sizes

RIVAROXABAN Vascular Zentiva 2,5 mg cpr pellic56
56 TABL
View
Buy us a coffee Explore the data